Welcome to Chinese Journal of Mycology,Today is Share:

Chinese Journal of Mycology 2010, Vol. 5  Issue (3): 144-147.

Previous Articles     Next Articles

Efficacy and safety of domestic amphotericin B in preemptive therapy of pulmonary invasive fungal infection in hematological disorder patients

CHAI Jun-yue1, WEI Na1, CUI Ting-ting1, XU Lan-ping2, HUANG Xiao-jun2   

  1. 1. Beijing No. 6 hospital, Beijing 100007, China;
    2. People’s Hospital & Institute of Hematology, Peking Univercity, Beijing 100044, China
  • Received:2009-10-19 Online:2010-06-28 Published:2010-06-28

Abstract: Objective To observe the therapeutic efficacy and adverse reactions of domestic amphotericin B in the treatment of invasive fungal infection (IFI) in hematological disorder patients.Methods A total of 45 cases of immunodepressive IFI patients receive domestic amphotericin B treatment from December 2004 to December 2008 in our hospital were retrospectively analyzed.Result All the cases patients received amphotericin B therapy for more than 2 weeks,in which the longest was 14 weeks,with 6 weeks as median.The total effective rate was 86.7%.Adverse reaction included hypokalemia,fever,aminotransferase,kidney failure,and gastrointestinal reactions.Conclusions Domestic amphotericin B is affirmed in the preemptive therapy for IFI in hematological patients with tolerable adverse reactions.

Key words: amphotericin B, hematological disorder, invasive fungal infection, preemptive therapy

CLC Number: